ACM
PHAT icon

Aquatic Capital Management’s Phathom Pharmaceuticals PHAT Stock Holding History

Aquatic Capital Management’s Portfolio PHAT Stock Details PHAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-40,852
Closed -$454K – 1623
2026
Q1 		$454K Buy
+40,852
New +$516K 0.01% 784
2024
Q3 		– Sell
-500
Closed -$5.15K – 1450
2024
Q2 		$5.15K Buy
+500
New +$5.15K ﹤0.01% 1144
2022
Q3 		– Sell
-400
Closed -$3K – 1467
2022
Q2 		$3K Sell
400
-600
-60% -$6.17K ﹤0.01% 1091
2022
Q1 		$14K Buy
1,000
+300
+43% +$4.85K 0.02% 586
2021
Q4 		$14K Buy
+700
New +$16.5K 0.03% 705

Other funds holding PHAT

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Aquatic Capital Management's PHAT Position: Q2 2026 in Review

Aquatic Capital Management sold out of Phathom Pharmaceuticals (PHAT) in Q2 2026, closing a stake of 40,852 shares — an estimated $454K sold.

Aquatic Capital Management first reported a position in PHAT in Q4 2021 and held it in 5 quarters. The position peaked at $454K in Q1 2026. 162 funds tracked by Wall St. Rank hold PHAT as of Q2 2026.

  • Aquatic Capital Management reported no remaining Phathom Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Aquatic Capital Management sold 40,852 Phathom Pharmaceuticals shares in Q2 2026, an estimated $454K.
  • Aquatic Capital Management first reported a position in Phathom Pharmaceuticals in Q4 2021 and held it in 5 quarters.
  • Aquatic Capital Management's Phathom Pharmaceuticals position peaked at $454K in Q1 2026.
  • 162 funds tracked by Wall St. Rank held Phathom Pharmaceuticals as of Q2 2026.

Based on Aquatic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.